Seniors suffer the most from antiquated FDA approval process

The Hill

4 September 2020 - Americans have been heartbroken as report after report shines a light on the COVID-19 pandemic sweeping through nursing homes and decimating some senior community populations. 

Not only have our seniors been struck in their final years with a hideous virus, but they are also the victims of an antiquated drug approval process that is nearly six decades old and in need of drastic improvement.

The fact is, we already have a model that works, which can be adapted for use in America with minor changes.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Geriatrics